Related Experiment Video

Updated: Apr 14, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

931

Molecular deregulation of signaling in lymphoid tumors

Valeria Spina1, Lavinia Martuscelli1, Davide Rossi1

  • 1Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.

European Journal of Haematology
|April 18, 2015
PubMed

Insights

Genomic studies reveal that lymphoid tumors hijack key cell signaling pathways. Understanding these genetic alterations is crucial for diagnosing and treating these cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Genomic studies have revolutionized the understanding of lymphoid tumors.
  • Malignant lymphoid cells exploit essential signaling pathways for survival and proliferation.

Purpose of the Study:

  • To review signaling pathways affected in lymphoid tumors.
  • To explore how genetic alterations in these pathways contribute to disease.

Main Methods:

  • Literature review of genomic studies on lymphoid tumors.
  • Analysis of signaling pathway dysregulation in cancer pathogenesis.

Main Results:

  • Key signaling pathways like B- and T-cell receptor, NF-κB, Toll-like receptor, cytokine, MAP kinase, and NOTCH are frequently altered.
  • These alterations are integral to the pathogenesis of lymphoid malignancies.

Conclusions:

  • Genetic mutations in signaling pathways are central to lymphoid tumor development.
  • Targeting these aberrant pathways offers potential therapeutic strategies for lymphoid cancers.
Keywords:
B-cell receptorMAP kinaseNF-κBNOTCHT-cell receptorToll-like receptorchronic lymphocytic leukemialymphomamutationsignaling

More Related Videos

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

3.0K
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.8K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.9K